CAS 1955514-80-3

N-Carbamoyl Linagliptin

Produit contrôlé

CAS : 1955514-80-3

Applications N-Carbamoyl Linagliptin is a derivative of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);

Formule : C₂₆H₂₉N₉O₃

Couleur et forme : Neat

Masse moléculaire : 515.57

Ref: TR-C176090

Linagliptin N-Aminoacyl Impurity

CAS : 1955514-80-3

Formule : C₂₆H₂₉N₉O₃

Masse moléculaire : 515.57

Ref: ST-EA-CP-L1019

N-Carbamoyl linagliptin

CAS : 1955514-80-3

N-Carbamoyl linagliptin is a synthetic drug that is a selective, reversible inhibitor of dipeptidyl peptidase-4 (DPP-4), an enzyme that breaks down the incretin hormones GLP-1 and GIP. This drug has been shown to help control blood glucose levels in patients with type 2 diabetes. It binds to the active site of DPP-4 and prevents it from breaking down GLP-1 and GIP, which leads to increased levels of these hormones in the body. N-Carbamoyl linagliptin has a long half life, making it suitable for once daily administration. It also lacks any significant interactions with other drugs or foods.

Formule : C₂₆H₂₉N₉O₃

Degré de pureté : Min. 95%

Masse moléculaire : 515.6 g/mol

Ref: 3D-FDD51480